During the current "silent" COVID-19 surge, you are at greater risk for getting infected with the SARS-CoV-2. Here's what to ...
Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...
Nuclein’s DASH SARS-CoV-2 & Flu A/B Test, which is designed for use with the DASH Rapid PCR System, has gained the US Food ...
Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its ...
The following is a summary of “Monocytic reactive oxygen species-induced T cell apoptosis impairs cellular immune response to ...
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug ...
A study in Ecuador reveals the rapid emergence of SARS-CoV-2 variants, highlighting the importance of strengthening genomic ...
Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDAâ„¢ (pemivibart) against XEC Centers for Disease ...
A study found that patients with COVID-19 may have a higher risk of developing new gastrointestinal (GI) disorders compared with matched controls, highlighting the need for further research on ...
SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly announces a significant milestone achieved by portfolio company Nuclein, LLC ...